AMH(anti-Müllerian hormone) is a hormone released by your ovaries that reflectshow many eggs you have left. An AMH test is a simple blood test, usually pricedat ₹800-₹2,500 in India. It is not necessary for every woman, but it isgenuinely useful if you are trying to conceive, planning to delay pregnancy, orhave PCOS, irregular cycles, or a family history of early menopause.
AMH stands foranti-Müllerian hormone. In women, it is produced by the small follicles(fluid-filled sacs) inside the ovaries that contain immature eggs. Becauseevery active follicle releases a little AMH, the level in your blood gives areasonable estimate of how many eggs you still have - your ovarian reserve.Higher levels suggest more remaining eggs; lower levels suggest fewer. Unlikemost reproductive hormones, AMH stays fairly steady through the menstrualcycle, so the test can be done on any day.
Ten years ago, almost nobody outside a fertility clinic asked about their AMH. Today, women in their late 20s and 30s in Gurgaon, Delhi NCR, and other Indian metros routinely book the test as part of a preventive health check-up, sometimes before they have any plans of pregnancy. The reason is simple: AMH is the closest thing medicine has to a measurable signal of how much fertility time you have left. It is not a crystal ball, and it does not predict whether you will get pregnant this year. But paired with your age and an antral follicle count, it is the single most useful number to start a fertility conversation with - which is exactly why the test has become popular, and also why it is sometimes ordered without a clear reason.
Honest answer: No; it is not necessary for every woman. But for several specific groups, it is one of the most informative tests in fertility care. The clearest way to decide is to look at who genuinely benefits, who does not, and what the result actually tells you.
AMH testing adds real value when the result will change a decision - about timing, treatment, or how closely you are monitored. The clearest groups are:
• Women trying to conceive who have not succeeded after 6-12 months of trying.
• Women aged 30 and above who are considering delaying pregnancy and want to know how much time they realistically have.
• Women considering egg freezing - AMH directly informs how a stimulation cycle is planned.
• Women preparing for IVF or IUI - AMH helps the fertility specialist choose medication doses.
• Women with PCOS (polycystic ovary syndrome), where AMH is often elevated and helps with both diagnosis and stimulation planning.
• Women with very irregular cycles, no periods, or suspected diminished ovarian reserve.
• Women with a family history of early menopause or premature ovarian insufficiency (ovarian function declining before age 40).
• Women who have had ovarian surgery, chemotherapy, or pelvic radiation, where reserve may have been affected.
AMH is not a general health screen. It can cause unnecessary anxiety when there is no fertility concern and no plan to act on the result. The test is usually not needed for:
• Healthy women in their 20s with regular cycles who are not actively planning pregnancy.
• Women who have already completed their family and are not considering further pregnancies.
• Women looking for a definitive prediction of natural fertility - AMH cannot give you that.
• Women looking for a menopause forecast - AMH gives general direction, not a date.
AMH is powerful because it is simple, but it is also one of the most misunderstood tests in fertility. Knowing what it does not tell you is as important as knowing what it does.
AMH varies between women of the same age, sometimes significantly. Common factors that influence the number include:
• Age: the strongest single influence - AMH peaks around age 25 and falls steadily after 30, more sharply after 35.
• PCOS (polycystic ovary syndrome) typically elevates AMH above average, sometimes 2-4 times the upper limit, due to the many small follicles in the ovaries.
• Diminished ovarian reserve: AMH is lower than expected for your age, often paired with a low antral follicle count.
• Premature ovarian insufficiency (POI): AMH is very low or undetectable, with ovarian function declining before age 40.
• Hormonal contraception: oral contraceptive pills, hormonal IUDs, and similar methods can lower AMH while in use; levels usually recover after stopping.
• Smoking: long-term smoking is consistently linked with lower AMH and earlier ovarian aging.
• Vitamin D status and BMI: very low vitamin D and significant underweight or overweight can mildly affect vitamin D levels.
• Previous ovarian surgery or chemotherapy can permanently lower AMH by reducing follicle numbers.
Lifestyle does not directly raise AMH, but it does protect your fertility and support the environment in which your remaining eggs develop. Practical starting points:
• Treat the result as one data point, not a verdict; pair it with your age and an antral follicle count before concluding.
• Stop smoking - this is the single most evidence-backed lifestyle change for ovarian health.
• Aim for a stable weight within a healthy range; very low or very high BMI can affect ovulation and hormone levels.
• Eat balanced meals with adequate protein, whole grains, healthy fats, and vegetables; chronic crash dieting disrupts hormones.
• Move regularly with moderate activity such as walking, yoga, or swimming.
• Prioritise sleep and stress management - both directly affect the brain-ovary hormonal axis.
• If you take hormonal contraception and are about to test, mention it to your specialist; testing 2-3 months after stopping gives a cleaner result.
• Discuss any supplements, such as vitamin D or CoQ10, with your fertility specialist before starting them, rather than self-prescribing from social media.
AMH on its own rarely guides treatment. A Cloudnine specialist will usually pair it with other findings before recommending next steps:
• Repeat AMH in the same lab if the first result was surprising or borderline.
• Antral follicle count and pelvic ultrasound to cross-check ovarian reserve and rule out cysts or fibroids.
• Hormonal panel - FSH, LH, TSH, prolactin, estradiol - to map the wider hormonal picture.
• Semen analysis for your partner; couple-based fertility evaluation is more useful than testing one person alone.
• Egg freezing discussion if you are 30-37 and not ready to try yet, especially with low or borderline AMH.
• Tailored ovulation induction, IUI, or IVF planning where conception support is needed.
Use the guide below as a starting point. Earlier evaluation usually means simpler treatment and more options preserved.
If any of these apply, you can book a fertility consultation with a Cloudnine Fertility specialist for an AMH test, an antral follicle count, and a clear plan based on your numbers.
AMH levels naturally decline with age, so a result that looks "low" in absolute terms may be perfectly normal for someone in their late 30s. The chart below shows commonly used reference ranges. Different labs use different assays, so always interpret your result against the lab's stated range.
General interpretation framework used by most fertility labs:
• Average: 1.0-3.0 ng/mL
• Low: under 1.0 ng/mL
• Severely low: 0.4 ng/mL or below
• High (often suggests PCOS): above 4.0 ng/mL